Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research and development, production, and marketing of therapeutic drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs; gene therapy/cell therapy drugs; and chemical drugs. It principally offers its products under the fields of nervous system related, infectious, gastrointestinal, urinary system, and autoimmune diseases. Staidson (Beijing) BioPharmaceuticals Co., Ltd. was founded in 2002 and is based in Beijing, China.
Stock data | 2024 | Change |
---|---|---|
Price | $0.8954255739184387 | N/A |
Market Cap | $427.81M | N/A |
Shares Outstanding | 477.77M | N/A |
Employees | 803.00 | N/A |